Intelligent Medicine Acqu... (IQMD)
NASDAQ: IQMD
· Real-Time Price · USD
11.04
0.79 (7.71%)
At close: Sep 17, 2024, 10:00 PM
Company Description
Intelligent Medicine Acquisition Corp. does not have significant operations.
The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses.
It intends to identify business opportunities in the field of life science.
The company was incorporated in 2021 and is based in Bethesda, Maryland.
Intelligent Medicine Acquisition Corp.
| Country | United States |
| IPO Date | Dec 27, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Gregory C. Simon |
Contact Details
Address: 9001 Burdette Road Bethesda, Maryland United States | |
| Website | n/a |
Stock Details
| Ticker Symbol | IQMD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001850051 |
| CUSIP Number | 45828D106 |
| ISIN Number | US45828D1063 |
| Employer ID | 86-2283527 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Gregory C. Simon | Chief Executive Officer, Chief Financial Officer & Director |
| Dr. Samir N. Khleif M.D., Ph.D. | Principal Advisor & Member of Advisory Committee |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| May 12, 2023 | 15-12G | Filing |
| May 02, 2023 | 25-NSE | Filing |
| Apr 27, 2023 | 3 | Filing |
| Apr 26, 2023 | 8-K | Current Report |
| Apr 17, 2023 | 10-K | Annual Report |
| Apr 13, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Apr 07, 2023 | 8-K | Current Report |
| Apr 05, 2023 | 8-K | Current Report |
| Apr 03, 2023 | NT 10-K | Filing |